Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide

The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda

The inherited disorder is caused by genetic mutations that affects haemoglobin production

Bacteroides fragilis in the gut improves immunity and immunotherapy treatment responses

The progressive neurological condition affects more than six million people worldwide

Bladder cancer, including papillary tumours, is the ninth most common cancer type worldwide